ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,884.80
0.46%
Dow Jones
40,211.72
0.53%
Brent Oil
83.975
-0.43%
Bitcoin
63,790.77
-1.64%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pyxis Oncology Inc (PYXS) Quote

Pyxis Oncology Inc

Pyxis Oncology Inc (PYXS)

NASDAQ
3.20
0.05
(1.59%)
Closed July 16 4:00PM
Delayed by 15 minutes
3.10
-0.10
(-3.13%)
After Hours: 7:07PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.10
Bid
3.10
Ask
3.25
Volume
374,327
3.15 Day's Range 3.28
1.35 52 Week Range 6.85
Market Cap
185.499M
Previous Close
3.15
Open
3.18
Last Trade
1
@
3.25
Last Trade Time
Financial Volume
$ 1,200,655
VWAP
3.2075
Average Volume (3m)
458,154
Shares Outstanding
58,888,473
Dividend Yield
-
PE Ratio
-2.55
Earnings Per Share (EPS)
-1.25
Revenue
-
Net Profit
-73.79M

About Pyxis Oncology Inc

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the ... Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
pyxisoncology.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Pyxis Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PYXS. The last closing price for Pyxis Oncology was $3.15. Over the last year, Pyxis Oncology shares have traded in a share price range of $ 1.35 to $ 6.85.

Pyxis Oncology currently has 58,888,473 shares outstanding. The market capitalization of Pyxis Oncology is $185.50 million. Pyxis Oncology has a price to earnings ratio (PE ratio) of -2.55.

PYXS Latest News

More News

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

June 28 2024
GlobeNewswire Inc.

Form 8-K - Current report

June 12 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 10 2024
Edgar (US Regulatory)

Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger

BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

June 10 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

June 07 2024
Edgar (US Regulatory)

Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

May 30 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.196.529209621992.913.32.817716162.99543783CS
4-0.66-17.55319148943.763.9052.816444793.129091CS
12-1.12-26.54028436024.224.782.814581543.69240125CS
260.834.78260869572.36.852.1256899084.46781681CS
520.4617.42424242422.646.851.354227263.99803041CS
156-15.9-83.684210526319191.15941484.21440993CS
260-15.9-83.684210526319191.15941484.21440993CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
SHOTWSafety Shot Inc
$ 0.41
(115.79%)
7.56k
DATSDatChat Inc
$ 1.89
(81.73%)
54.75M
CYNCYNGN Inc
$ 9.18
(53.77%)
17.79M
SCNIScinai Immunotherapeutics Ltd
$ 5.80
(42.86%)
29.37M
ASLNASLAN Pharmaceuticals Ltd
$ 1.36
(-46.67%)
1.16M
KZIAKazia Therapeutics Ltd
$ 0.5593
(-37.56%)
15.34M
LCFYLocafy Ltd
$ 3.5597
(-36.32%)
584.38k
NAASNaaS Technology Inc
$ 2.82
(-33.02%)
1.94M
ZENVZenvia Inc
$ 1.67
(-26.75%)
658.26k
FFIEFaraday Future Intelligent Electric Inc
$ 0.5152
(22.09%)
217.92M
NVDANVIDIA Corporation
$ 128.44
(-0.62%)
208.32M
SQQQProShares UltraPro Short QQQ
$ 7.46
(-0.67%)
155.14M
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
TSLATesla Inc
$ 252.64
(1.78%)
147.31M

PYXS Discussion

View Posts
Monksdream Monksdream 4 months ago
PYXS under $5
👍️0
Awl416 Awl416 5 months ago
Pyxis Oncology Announces $50 Million Private Placement
👍️0
euroconversions euroconversions 10 months ago
Insiders buying, always a good sign.
PYXS Long
👍️0
jack7377 jack7377 1 year ago
PYSX#$$: Hey Bulba and JuneBugs , this Log Legged Loin Puppy is getting ready to Break it's Chain,Leap and go on an Epic Run North. Friday's 1st Qtr Financials are going to make this spring 200-300%.
👍️0
TheFinalCD TheFinalCD 1 year ago
I did, nice P&D

https://www.tiktok.com/@stockdads/video/7217125391520091434
👍️0
SpaceTimeRift777 SpaceTimeRift777 1 year ago
Wouldn't touch it until we see if that $3 support can hold
GL
👍️0
spencer22 spencer22 1 year ago
Perfect example of dilution,in other words a classic pump and dump in my opinion!
👍️ 1
0210 0210 1 year ago
7). $10.75 PYXS Target Price @ Fin Viz.

8). BUY Rating $14.00 PYXS PT @ Market Beat.

9). $10.75 PT +++Positive+++ Short, Medium and Long Term Performance Outlook, Yahoo Finance.

10). BUY Rating @Reuters.
👍️0
0210 0210 1 year ago
buyin' dips $4.00 - $4.10. 14m BUYs (+5m?) vs. 12m Sells this Friday. hmmm.....

1). 88% Buy, up from 72% buy last week and 40% Buy, a month ago @Barchart.

2). Stay Long @ American Bulls.

3). $10.75 Price Target, from 5 analysts @Barrons.

4). $4.00 >$11.50 > $16.00 Price Targets @CNN Business.

5). HOLD Rating @ Zacks.

6). $11.22 TP mean rating, Chartmill.
👍️0
interloper interloper 1 year ago
I just heard the same thing from a cousin who said it was on Reddit.
👍️0
Jess070283 Jess070283 1 year ago
That dip was a gift. Loaded way oversold.
👍️0
magacrew2020 magacrew2020 1 year ago
potential halt at $2. seems to be fair value
👍️0
da_stock_analyst da_stock_analyst 1 year ago
#PYXS ?? big squeeze coming??!! Attractive bullish chart! $PYXS
👍️0
Pyramid2 Pyramid2 1 year ago
* * > $7 halt < * *

Went short $6.85 and they halted it $6.92 and she dropped. I thought not again just like SVIBQ and it will open 2 weeks later at $100. I am still waiting to get my trading groove back. This thing has been a rocket from $3.92 yesterday. No position now closed out on $6 close.

glta.
👍️0
SpaceTimeRift777 SpaceTimeRift777 1 year ago
Better lock profits today this will come back down to earth

Way Overbought
👍️0
SpaceTimeRift777 SpaceTimeRift777 1 year ago
One hell of a Moon Market pump
👍️0
jakec21 jakec21 1 year ago
Please post something that you have proof. You r on my radar alert
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
PYXS....MONSTER TAKING OFF!!
👍️0
PickItToWin PickItToWin 1 year ago
Thorough DD is how I found my info and jumped in at $2. Definitely happy with my ROI this week, hope others took advantaged as well. GLTA
👍️0
eastunder eastunder 1 year ago
It's from a tiktok video...

Where all valid information comes from.
👍️0
da_stock_analyst da_stock_analyst 1 year ago
#PYXS ?? can it double from here? very bullish chart! see the video $PYXS
👍️0
TheFinalCD TheFinalCD 1 year ago
hmmmm, any info or articles to back your post up?


Message in reply to:
Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
👍️0
Jess070283 Jess070283 1 year ago
Beast!$$$
👍️0
Randyfloyd420 Randyfloyd420 1 year ago
Yea what a joke
👍️0
eastunder eastunder 1 year ago
I did. There is nothing that I found that backed that up.

So if you have something, cam you please post a link?

I really am curious.

I don't see Pelosi buying something like this.

Why?
👍️0
PickItToWin PickItToWin 1 year ago
Just do a Google search on Pyxs and Nancy Pelosi. She’s not the only one buying it up.
👍️0
eastunder eastunder 1 year ago
How do you know that?
👍️0
PickItToWin PickItToWin 1 year ago
Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
👍️0
Amatuer17 Amatuer17 1 year ago
Seems an interesting play in ADC
👍️0

Your Recent History

NASDAQ
PYXS
Pyxis Oncology
TG
MOH
Lvmh Moet Hennessy Louis...
BOV
MCOR34
Moodys
LSE
EMCR
Ishr $ Em
LSE
HCEG
Healthcare Enterprise
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved